GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Moss Genomics Inc (XCNQ:MOSS) » Definitions » Total Receivables

Moss Genomics (XCNQ:MOSS) Total Receivables : C$0.02 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Moss Genomics Total Receivables?

Moss Genomics's Total Receivables for the quarter that ended in Dec. 2024 was C$0.02 Mil.


Moss Genomics Total Receivables Historical Data

The historical data trend for Moss Genomics's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moss Genomics Total Receivables Chart

Moss Genomics Annual Data
Trend Jun22 Jun23
Total Receivables
- 0.02

Moss Genomics Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Dec24
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.02 0.02 0.02

Moss Genomics Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


Moss Genomics Total Receivables Related Terms

Thank you for viewing the detailed overview of Moss Genomics's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Moss Genomics Business Description

Traded in Other Exchanges
Address
1030 West Georgia Street, Suite 908, Vancouver, BC, CAN, V6E 2Y3
Moss Genomics Inc is an emerging consumer genomics company that provides personalized health, anti-aging, and wellness solutions based on genomic, microbiome, and epigenome data. The company aims to eliminate barriers in healthcare by offering accessible, affordable at-home testing along with easy-to-understand actionable results.
Executives
Lucas Cahill 10% Security Holder

Moss Genomics Headlines

No Headlines